News | July 29, 2014

IBA Shows Proteus ONE With Ambient Experience To Calm Patients

IBA Proteus ONE With Ambient Experience Proton Radiation Therapy

July 29, 2014 —IBA (Ion Beam Applications SA) presented its Proteus ONE and Ambient Experience designed with Philips at the Annual Meeting of the American Association of Physicists in Medicine (AAPM) from July 20-24, 2014 in Austin, Texas.

IBA held a Proton Therapy Symposium at AAPM July 22 to present the advantages of Proteus ONE and show how it enhances IMPT accuracy with advanced image guidance, while also offering a soothing patient experience through its clinically optimized design, the Red Dot Best of the Best award-winning Ambient Experience.

Working with clinicians and nurses in the development of proton therapy worldwide over the last 25 years has led the IBA team to understand that successful treatment does not only depend on proton beam physics. Proteus ONE has been designed to enhance patient experience and to facilitate medical staff's daily practice at the same time.

Based on insights from patient groups, healthcare staff and experts, Philips and IBA have managed to develop a solution that improves the overall patient and staff experience, turning a cold, impersonal environment into a comforting and reassuring one. Designed for Proteus ONE, integrating technology, spatial design and workflow improvements to create comfortable, stress-reducing environments, the Ambient Experience has been awarded the "International Red Dot Best of the Best Award 2014" for its contribution to patient well being.

For more information: www.iba-worldwide.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...